Company Profile

Exscientia

Exscientia has developed a functional precision oncology platform that successfully guides treatment selection and improves patient outcomes

Headquarters

Oxford, England

Year Founded

2012

Top Impacted Industries

Pharmaceuticals, Biotechnology, Drug Discovery, Life Sciences, Healthcare

About Us

Exscientia develops AI-driven drug discovery technology that uses generative design, machine learning, active learning, and automated analysis to design and prioritize potential drug molecules. Its platform combines computational models with laboratory experiments to explore chemical space and advance drug candidates for complex diseases.

Related Articles

Trending Companies

Latest Articles

futureTEKnow is focused on identifying and promoting creators, disruptors and innovators, and serving as a vital resource for those interested in the latest advancements in technology.

© 2026 All Rights Reserved.